The rise of copyright’s blockbuster initially fueled a surge for the drug industry, however recent developments present a uncertain scenario for investors. Off-patent competitors are eating into earnings, and https://franceszrwc064238.blogars.com/39674619/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-play